The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
PRIMAQUINE: REPORT FROM CDC EXPERT MEETING ON MALARIA CHEMOPROPHYLAXIS I
Open accessAbstract
Primaquine phosphate has been used for preventing relapse of Plasmodium vivax and P. ovale malaria since the early 1950s, based on its ability to kill latent (hypnozoite) and developing liver stages of these parasites. There are three uses for primaquine in malaria: radical cure of established infection with P. vivax or P. ovale malaria; presumptive anti-relapse therapy (PART; terminal prophylaxis) in persons with extensive exposure to these parasites; and primary prophylaxis against all malaria species. All persons for whom primaquine is being considered must have a glucose-6-phosphate dehydrogenase (G6PD) enzyme level checked before use, and persons who have a deficiency of G6PD must not take primaquine for prophylaxis or PART. The recommended adult dose for PART based on clinical trials and expert opinion is 30 mg base daily for 14 days, started on return from a malarious region and overlapping with a blood schizonticide. The adult dose for primary prophylaxis is 30 mg daily begun 1 day before travel and continued for 7 days after return. This review will examine the evidence for these recommendations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Committee on Infectious Diseases
Nider, H. (1989) · Archives of Dermatology · doi:10.1001/archderm.1989.01670190156031 · Cited by 1,911
Drugs in Pregnancy and Lactation
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-11-902_3 · Cited by 1,075
(2001) · PsycEXTRA Dataset · doi:10.1037/e548252006-001 · Cited by 1,018
McEvoy, G. K. (1994) · Oncology Issues · doi:10.1080/10463356.1994.11904493 · Cited by 888
Primaquine Therapy for Malaria
Baird, J. K., & Hoffman, S. L. (2004) · Clinical Infectious Diseases · doi:10.1086/424663 · Cited by 435
Self-citationGlucose-6-Phosphate Dehydrogenase Deficiency
Desforges, J. F., & Beutler, E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101173240306 · Cited by 430
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-502_4 · Cited by 360
Inhibition and induction of human cytochrome P450 (CYP) enzymes
PELKONEN, O., MÄEENPÄEÄ, J., TAAVITSAINEN, P., RAUTIO, A., & RAUNIO, H. (1998) · Xenobiotica · doi:10.1080/004982598238886 · Cited by 358
Medina, I., Mills, J., Leoung, G., Hopewell, P. C., Lee, B., Modin, G., Benowitz, N., & Wofsy, C. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199009203231202 · Cited by 320
Guide to Development of Practice Guidelines
Kish, M. A. (2001) · Clinical Infectious Diseases · doi:10.1086/319366 · Cited by 276
Drug-Induced Methaemoglobinaemia Treatment Issues
Coleman, M. D., & Coleman, N. A. (1996) · Drug Safety · doi:10.2165/00002018-199614060-00005 · Cited by 275
Clinical Pharmacokinetics of Antimalarial Drugs
White, N. J. (1985) · Clinical Pharmacokinetics · doi:10.2165/00003088-198510030-00001 · Cited by 267
Malaria eradication on islands
Kaneko, A., Taleo, G., Kalkoa, M., Yamar, S., Kobayakawa, T., & Björkman, A. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03127-5 · Cited by 225
Malaria-Related Deaths among U.S. Travelers, 1963–2001
Newman, R. D., Parise, M. E., Barber, A. M., & Steketee, R. W. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-7-200410050-00012 · Cited by 208
Self-citationSafrin, S., Finkelstein, D. M., Feinberg, J., Frame, P., Simpson, G., Wu, A., Cheung, T., Soiero, R., Hojczyk, P., & Black, J. R. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-9-199605010-00003 · Cited by 205
Delayed Onset of Malaria — Implications for Chemoprophylaxis in Travelers
Schwartz, E., Parise, M. E., Kozarsky, P. E., & Cetron, M. S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021592 · Cited by 185
Self-citationHemolytic Anemia in Disorders of Red Cell Metabolism
Beutler, E. (1978) · Springer eBooks · doi:10.1007/978-1-4684-2457-7 · Cited by 169
Can primaquine therapy for vivax malaria be improved?
Baird, J. K., & Rieckmann, K. H. (2003) · Trends in Parasitology · doi:10.1016/s1471-4922(03)00005-9 · Cited by 169
Self-citationMihaly, G., Ward, S., Edwards, G., Orme, M., & Breckenridge, A. (1984) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1984.tb02369.x · Cited by 164
Phillips, E. J., Keystone, J. S., & Kain, K. C. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.5.1171 · Cited by 161
Primaquine Resistance in Plasmodium vivax
Collins, W. E., & Jeffery, G. M. (1996) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1996.55.243 · Cited by 158
The Safety of Antimalarial Drugs in Pregnancy
Phillips‐Howard, P. A., & Wood, D. (1996) · Drug Safety · doi:10.2165/00002018-199614030-00001 · Cited by 150
Alving, A. S., JOHNSON, C. F., Tarlov, A. R., Brewer, G. J., Kellermeyer, R. W., & Carson, P. E. (1960) · Europe PMC (PubMed Central) · Cited by 144
Blood Stage Antimalarial Efficacy of Primaquine in Plasmodium vivax Malaria
Pukrittayakamee, S., Vanijanonta, S., Chantra, A., Clemens, R. L., & White, N. J. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.4.932 · Cited by 122
Bapiro, T. E., Egnell, A., Hasler, J. A., & Masimirembwa, C. M. (2001) · PubMed · Cited by 117
An Outbreak of Malaria in US Army Rangers Returning From Afghanistan
Kotwal, R. S. (2005) · JAMA · doi:10.1001/jama.293.2.212 · Cited by 116
Primaquine for Prevention of Malaria in Travelers
Baird, J. K., Fryauff, D. J., & Hoffman, S. L. (2003) · Clinical Infectious Diseases · doi:10.1086/379714 · Cited by 116
Self-citationTreatment of Chloroquine-Resistant Plasmodium vivax with Chloroquine and Primaquine or Halofantrine
Baird, J. K., Basri, H., Subianto, B., et al. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1678 · Cited by 115
Self-citationMihaly, G., Ward, S. A., Edwards, G., Nicholl, D., Orme, M., & Breckenridge, A. (1985) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1985.tb02709.x · Cited by 115
Malaria Surveillance - United States, 2002
Shah, S. N., Filler, S. G., Causer, L. M., Rowe, A. K., Bloland, P. B., & Barber, A. M. (2004) · PsycEXTRA Dataset · doi:10.1037/e566402006-002 · Cited by 108
Malaria surveillance--United States, 2004.
Skarbinski, J., James, E. M., Causer, L. M., Barber, A. M., Mali, S., Nguyen-Dinh, P., Roberts, J. M., Parise, M. E., Slutsker, L., & Newman, R. D. (2006) · PubMed · Cited by 105
Self-citationRaaska, K., & Neuvonen, P. J. (2000) · European Journal of Clinical Pharmacology · doi:10.1007/s002280000192 · Cited by 91
(1954) · doi:10.1016/s0140-6736(54)92225-4 · Cited by 90
Leslie, T. J., Rab, M. A., Ahmadzai, H., Durrani, N., Fayaz, M., Kolaczinski, J. H., & Rowland, M. (2004) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(03)00041-5 · Cited by 77
CHANGES IN MALARIA INCIDENCE AFTER MASS DRUG ADMINISTRATION IN NICARAGUA
Garfield, R., & Vermund, S. H. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90523-8 · Cited by 75
Treatment of vivax malaria on the western border of Thailand
Luxemburger, C., van Vugt, M., Jonathan, S., McGready, R. M., Looareesuwan, S., White, N. J., & Nosten, F. H. (1999) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(99)90149-9 · Cited by 71
Schwartz, E., & Regev‐Yochay, G. (1999) · Clinical Infectious Diseases · doi:10.1086/313527 · Cited by 69
Weber, M. K., Floyd, R. L., Riley, E. P., & Snider, D. E. (2002) · PsycEXTRA Dataset · doi:10.1037/e548402006-002 · Cited by 63
Primaquine metabolism by human liver microsomes: effect of other antimalarial drugs
Bangchang, K. N., Karbwang, J., & Back, D. J. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90453-p · Cited by 61
Primaquine: Pharmacokinetics, metabolism, toxicity and activity
Warhurst, D. C. (1987) · Parasitology Today · doi:10.1016/0169-4758(87)90128-1 · Cited by 56
Low response of Colombian strains of Plasmodium vivax to classical antimalarial therapy.
Arias, A. E., & Corredor, A. (1989) · PubMed · Cited by 56
Malaria surveillance--United States, 2003.
Eliades, M. J., Shah, S. N., Nguyen-Dinh, P., Rd, N., Barber, A. M., Nguyen-Dinh, P., Roberts, J. M., Mali, S., Parise, M. E., Barber, A. M., et al. (2005) · PubMed · Cited by 52
Self-citationChloroquine sensitivity of Plasmodium vivax in Thailand
Looareesuwan, S., Wilairatana, P., Krudsood, S., Treeprasertsuk, S., Singhasivanon, P., Bussaratid, V., Chokjindachai, W., Viriyavejakul, P., Chalermrut, K., Walsh, D. S., et al. (1999) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1999.11813417 · Cited by 47
Malaria surveillance--United States, 2001.
Filler, S. G., Causer, L. M., Newman, R. D., Barber, A. M., Roberts, J. M., MacArthur, J., Parise, M. E., & Steketee, R. W. (2003) · PubMed · Cited by 47
Self-citationImported Plasmodium vivax Malaria: Demographic and Clinical Features in Nonimmune Travelers
Elliott, J., O'Brien, D. P., Leder, K. S., Kitchener, S. J., Schwartz, E., Weld, L. H., Brown, G. V., Kain, K. C., Torresi, J., & the GeoSentinel Surveillance Network (2006) · Journal of Travel Medicine · doi:10.2310/7060.2004.19004 · Cited by 46
Mefloquine metabolism by human liver microsomes
Bangchang, K. N., Karbwang, J., & Back, D. J. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90638-y · Cited by 43
Diagnostic and Therapeutic Pitfalls Associated with Primaquine-Tolerant Plasmodium vivax
Spudick, J. M., Garcia, L. S., Graham, D. M., & Haake, D. A. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.2.978-981.2005 · Cited by 39
Dapsone- and Primaquine-Induced Methemoglobinemia in HIV-Infected Individuals
Sin, D. D., & Shafran, S. D. (1996) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199608150-00006 · Cited by 35
Pa, R., Toaliu, H., Kaneko, A., et al. (1992) · PubMed · Cited by 33
Baird, J. K., Wiady, I., Sutanihardja, A., Suradi, S., Purnomo, P., Basri, H., Sekartuti, Ayomi, E., Fryauff, D. J., & Hoffman, S. L. (2002) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2002.66.659 · Cited by 27
Self-citationPowell, R. D., & Brewer, G. J. (1967) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1967.16.693 · Cited by 27
The treatment of malaria in glucose-6-phosphate dehydrogenase deficient patients in Sabah
Khoo, K.-K. (1981) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1981.11687489 · Cited by 26
Adequate Primaquine for Vivax Malaria
Kitchener, S. J., Nasveld, P., Bennett, S. M., et al. (2006) · Journal of Travel Medicine · doi:10.2310/7060.2005.12306 · Cited by 24
Distribution of primaquine in human blood: drug-binding to alpha 1-glycoprotein.
Kennedy, E. J., & Frischer, H. (1990) · PubMed · Cited by 16
Back, D. J., Breckenridge, A., Grimmer, S. F. M., Orme, M. L., & Purba, H. S. (1984) · Contraception · doi:10.1016/0010-7824(84)90092-1 · Cited by 12
Normal immunological responses in mice treated with chloroquine, quinine and primaquine
Thong, Y. H., Ferrante, A., & Secker, L. K. (1981) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(81)90021-3 · Cited by 7
Primaquine Prophylaxis against Malaria
Barry, M. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00010 · Cited by 7
Cited by
Bousema, T., & Drakeley, C. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-10 · Cited by 746
Primaquine revisited six decades after its discovery
Vale, N., Moreira, R., & Gomes, P. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2008.08.011 · Cited by 367
Imaging of Plasmodium Liver Stages to Drive Next-Generation Antimalarial Drug Discovery
Meister, S., Plouffe, D. M., Kuhen, K. L., Bonamy, G. M. C., Wu, T., Barnes, S. W., Bopp, S. E., Borboa, R., Bright, A. T., Che, J., et al. (2011) · Science · doi:10.1126/science.1211936 · Cited by 338
The Practice of Travel Medicine: Guidelines by the Infectious Diseases Society of America
Hill, D. R., Ericsson, C. D., Pearson, R. D., Keystone, J. S., Freedman, D. O., Kozarsky, P. E., DuPont, H. L., Bia, F. J., Fischer, P. R., & Ryan, E. T. (2006) · Clinical Infectious Diseases · doi:10.1086/508782 · Cited by 296
Self-citationUK malaria treatment guidelines
Lalloo, D. G., Shingadia, D., Pasvol, G., Chiodini, P. L., Whitty, C. J., Beeching, N. J., Hill, D. R., Warrell, D. A., & Bannister, B. A. (2007) · Journal of Infection · doi:10.1016/j.jinf.2006.12.003 · Cited by 272
Self-citation
Metadata
- Authors
- HILL, D. R., BAIRD, J. K., PARISE, M. E., LEWIS, L. S., RYAN, E. T., & MAGILL, A. J.
- Venue
- The American Journal of Tropical Medicine and Hygiene
- Published
- 2006-09
- Volume
- 75
- Issue
- 3
- Pages
- 402-415
- ISSN
- 0002-9637 (ISSN-L)
- OpenAlex
- W2004295690
- Cited by
- 334
- References
- 57
- FWCI
- 16.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.